CN104459158A - Aspartate transaminase mitochondrial isozyme detection kit - Google Patents

Aspartate transaminase mitochondrial isozyme detection kit Download PDF

Info

Publication number
CN104459158A
CN104459158A CN201410805113.9A CN201410805113A CN104459158A CN 104459158 A CN104459158 A CN 104459158A CN 201410805113 A CN201410805113 A CN 201410805113A CN 104459158 A CN104459158 A CN 104459158A
Authority
CN
China
Prior art keywords
reagent
detection kit
aspartate aminotransferase
kit according
damping fluid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410805113.9A
Other languages
Chinese (zh)
Other versions
CN104459158B (en
Inventor
邹炳德
邹继华
陆慧贤
黄辛雷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meikang biological Polytron Technologies Inc
Original Assignee
NINGBO MEIKANG BIOTECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NINGBO MEIKANG BIOTECHNOLOGY Co Ltd filed Critical NINGBO MEIKANG BIOTECHNOLOGY Co Ltd
Priority to CN201410805113.9A priority Critical patent/CN104459158B/en
Publication of CN104459158A publication Critical patent/CN104459158A/en
Application granted granted Critical
Publication of CN104459158B publication Critical patent/CN104459158B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses an aspartate transaminase mitochondrial isozyme detection kit, comprising: reagents 1: 0.02-0.5mol/L of buffer solution of which pH value is 6.5-8.0, 0.15-0.3mol/L of L-potassium aspartate, 0.3-5KU/L of malic dehydrogenase, 0.3-5KU/L of lactic dehydrogenase, 5-20mL/L of human cAST antibody, 0.01-3% of antibody stabilizer, 0.01-10% of enzyme stabilizer and 0.01-1% of preservative; and reagents 2: 0.02-0.5mol/L of buffer solution of which pH value is 7.0-9.0, 0.005-0.02mol/L of alpha-ketoglutarate, 0.1-0.5mmol/L of reduced coenzyme I, 0.01-1% of preservative and 0.01-10% of reduced coenzyme I stabilizer. The kit has the advantage of good stability.

Description

Aspartate aminotransferase Mitochondria Isoenzyme detection kit
Technical field
The present invention relates to technical field of medical examination, be specifically related to a kind of aspartate aminotransferase Mitochondria Isoenzyme (m-AST or mAST Mitochondrial form aspartate amino transferase) detection kit.
Background technology
Aspartate aminotransferase (Aspartate aminotransferase, AST) is extensively present in the various histocyte of human body, especially abundant with liver, heart tissue's cell content, and in normal human serum, AST activity is very low.In human body there are two kinds of isodynamic enzymes in AST, and one is cAST, is mainly derived from cytoplasm, and another kind is mAST, is present in mitochondria.These two kinds of isodynamic enzymes are variant in genomic constitution, all different in amino acid composition, immunological characteristic and half life period in vivo etc.
When the slight pathology of body, histiocytic permeability of cell membrane increases, and cAST permeate through cell membranes enters in hematological system, but mAST has the protection of two-layer mitochondrial membrane, is not easily released into blood; And when body serious disease, there is meronecrosis, mitochondria disintegration, the mAST be attached on mitochondria can discharge into rapidly in blood.Therefore, serum mAST activity can reflect histiocytic degree of necrosis, if detect high-level mAST in serum, then shows cardiac muscle, liver is badly damaged; The half life period of mAST in blood is shorter than cAST in addition, and when cell no longer destroys or repairs, in serum, mAST is down to normal level very soon, and therefore mAST is again the evaluation index of cardiac muscle, liver damage prognosis, has important value to the diagnosis of disease, treatment.
At present, in serum, mAST measures and mainly contains electrophoresis, chromatography and immunodepression etc., especially possesses advantage that is special, accurate, fast and convenient, that can be used for Aulomatizeted Detect with immunodepression, is suitable for the application of clinical extensive sample.Its Cleaning Principle is: in people source cAST antibody and serum sample, cAST effect forms immune complex, make cAST activity inhibited, and mAST activity is unaffected, mAST can with the reaction coupling of malic dehydrogenase (MDH) catalysis, make reduced coenzyme Ⅰ (NADH) be oxidized to NAD +, by detecting the speed that certain wave strong point NADH absorbance declines, can be calculated the activity of mAST.Reaction equation is as follows:
From above-mentioned reaction principle, people source cAST antibody is the critical materials of mAST determination of activity system, and can people source cAST antibody becomes the key of mAST activity in Accurate Measurement human serum sample.But, according to this area general knowledge, when antibody is with solution state long-term storage, the phenomenons such as the generation of chemolysis thing, the generation of insoluble agglutinator, the generation of solubility associated matter can be there is, thus cause the biologically active of antibody greatly to reduce, therefore antibody is most to save as the best under-20 DEG C of environment, in order to keep the activity of antibody, can only provisional configuration kit in use, and this is not obviously suitable for commercial liquid reagent box.
Summary of the invention
The present invention is directed to the above-mentioned deficiency of prior art, a kind of aspartate aminotransferase Mitochondria Isoenzyme detection kit of excellent in stability is provided.
In order to solve the problems of the technologies described above, the technical solution used in the present invention is: a kind of aspartate aminotransferase Mitochondria Isoenzyme detection kit, and this kit is made up of following two kinds of liquid reagents, wherein:
Reagent 1:
Reagent 2:
Wherein, damping fluid in described reagent 1 or 2 can be one or more in TRIS buffer, two (2-hydroxyethanesulfonic acid) damping fluid of piperazine-N, N-, N-2-hydroxyethyl piperazine-N '-ethanesulfonic acid buffer, N-tri-(methylol) methylamino-2-hydroxy-propanesulfonic acid damping fluid, 4-(2-hydroxyethyl)-1-piperazine propane sulfonic acid damping fluid, 3-morpholine-2-hydroxypropionate sodium damping fluid;
Described antibody stabilization agent can be the one during glycocoll and citric acid, glycocoll and heparin, citric acid and histidine, heparin and histidine combine, the combination of preferred histidine and citric acid, the weight proportion between said sequence combination is: histidine: citric acid=10 ~ 100:1;
Described enzyme stabilizers is one or several in trehalose, sucrose, bovine serum albumin(BSA), glycerine, Tween 80;
Described antiseptic is NaN 3or the one in proclin300;
Described reduced coenzyme Ⅰ stabilizing agent is one or more in trehalose, bovine serum albumin(BSA), glycerine, Tween 80.
Advantage of the present invention and beneficial effect: mAST detection kit of the present invention is by adding antibody stabilization agent, to improve in kit people source cAST antibody in the stability of liquid condition, enzyme stabilizers and reduced coenzyme Ⅰ stabilizing agent is added additionally by combining, therefore more effectively ensure that the stability of kit entirety, greatly meet the demand of clinical detection and diagnosis.
Specific embodiment
Below in conjunction with embodiment, the present invention is further described in detail, but is not limited to this.
Embodiment 1
A kind of mAST detection kit, comprises reagent 1 and reagent 2, wherein:
Reagent 1:
Reagent 2:
Embodiment 2
A kind of mAST detection kit, comprises reagent 1 and reagent 2, wherein:
Reagent 1:
Reagent 2:
Below the stability of the embodiment of the present invention 1 gained reagent is described.
1, Antibody stability:
Be configured to down three group reagents by the following method:
Organize 1.: according to recipe configuration reagent described in embodiment 1, and in 2 ~ 8 DEG C of storages 18 months;
Organize 2.: except not adding antibody stabilization agent, all the other are according to recipe configuration reagent described in embodiment 1, and in 2 ~ 8 DEG C of storages 18 months;
Organize 3.: after 18 months, newly configure reagent (antibody added is-20 DEG C of frozen same a collection of antibody) according to filling a prescription described in embodiment 1.
Above-mentioned three group reagents are placed on automatic clinical chemistry analyzer, location parameter is set in accordance with the following methods and the activity of Simultaneously test 10 parts of human serum mAST: temperature of reaction 37 DEG C, test predominant wavelength 340nm, test commplementary wave length 405nm, tested serum sample/blank with reagents ratio is: sample/contrast: reagent 1: reagent 2=18uL:240uL:60uL, reacts for falling reaction.Method of testing is: sample/contrast first mixes with reagent 1 hatches 5min, add reagent 2 afterwards, reading is started after in 1.5min, and under mensuration wavelength, monitor the change of each sample absorbance in 3min continuously, calculate the absorbance changing value △ A/min of average minute clock, and according to following formulae discovery mAST activity value: mAST activity (U/L)=(△ A measure/ min-△ A blank/ min) × F (2840.3).Measurement result is as shown in table 1.
Table 1mAST detection kit Antibody stability result
As can be seen from table 1 result: the reagent not adding antibody stabilization agent is in storage after 18 months, measured result exceeds about 10% than the reagent of new configuration, the antibody illustrating in liquid reagent is deposited 18 months artifact activity and is decreased, and rejection ability declines to some extent; And with the addition of the reagent of antibody stabilization agent, the result of mensuration with newly join reagent and still can be consistent (± 3%), show that antibody stabilization agent can protect the biologically active of antibody in liquid reagent effectively, improve the stability of antibody.
2, thermal stability:
According to recipe configuration reagent described in embodiment 1, be placed in heat damage 7d under 37 DEG C of water bath, measure and record the blank absorbency changing value of reagent in 7d, and measuring the mAST value of 10 parts of human serum samples in 7d.
Table 2mAST detects each Blank absorbance values in reagent 37 DEG C of water-bath 7d
Determination of serum result after table 3mAST detection reagent 37 DEG C of water-bath 7d
As can be seen from table 2 and table 3 result, 7d placed by reagent 37 DEG C, and blank absorbency is without significant change, and determination of serum result is close to contrast, and result is good.
People source of the present invention cAST antibody is commercially available prod, as Thermo scientific company the GOT1Antibodies that sold.
The above embodiment of the present invention can not be used for limiting the present invention to explanation of the present invention, and any change in the implication suitable with claims of the present invention and scope, all should think to be included in the scope of claims.

Claims (7)

1. an aspartate aminotransferase Mitochondria Isoenzyme detection kit, is characterized in that: this kit is made up of reagent 1 and reagent 2 two kinds of liquid reagents, wherein:
Reagent 1:
Reagent 2:
2. aspartate aminotransferase Mitochondria Isoenzyme detection kit according to claim 1, it is characterized in that: the damping fluid in described reagent 1 or 2 is one or more in TRIS buffer, two (2-hydroxyethanesulfonic acid) damping fluid of piperazine-N, N-, N-2-hydroxyethyl piperazine-N '-ethanesulfonic acid buffer, N-tri-(methylol) methylamino-2-hydroxy-propanesulfonic acid damping fluid, 4-(2-hydroxyethyl)-1-piperazine propane sulfonic acid damping fluid, 3-morpholine-2-hydroxypropionate sodium damping fluid.
3. aspartate aminotransferase Mitochondria Isoenzyme detection kit according to claim 1, is characterized in that: described antibody stabilization agent is the one during glycocoll and citric acid, glycocoll and heparin, citric acid and histidine, heparin and histidine combine.
4. aspartate aminotransferase Mitochondria Isoenzyme detection kit according to claim 3, is characterized in that: described antibody stabilization agent is the combination of histidine and citric acid.
5. aspartate aminotransferase Mitochondria Isoenzyme detection kit according to claim 1, is characterized in that: described enzyme stabilizers is one or several in trehalose, sucrose, bovine serum albumin(BSA), glycerine, Tween 80.
6. aspartate aminotransferase Mitochondria Isoenzyme detection kit according to claim 1, is characterized in that: described antiseptic is NaN 3or the one in proclin300.
7. aspartate aminotransferase Mitochondria Isoenzyme detection kit according to claim 1, is characterized in that: described reduced coenzyme Ⅰ stabilizing agent is one or more in trehalose, bovine serum albumin(BSA), glycerine, Tween 80.
CN201410805113.9A 2014-12-22 2014-12-22 Aspartate aminotransferase Mitochondria Isoenzyme detection kit Active CN104459158B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410805113.9A CN104459158B (en) 2014-12-22 2014-12-22 Aspartate aminotransferase Mitochondria Isoenzyme detection kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410805113.9A CN104459158B (en) 2014-12-22 2014-12-22 Aspartate aminotransferase Mitochondria Isoenzyme detection kit

Publications (2)

Publication Number Publication Date
CN104459158A true CN104459158A (en) 2015-03-25
CN104459158B CN104459158B (en) 2016-06-22

Family

ID=52905542

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410805113.9A Active CN104459158B (en) 2014-12-22 2014-12-22 Aspartate aminotransferase Mitochondria Isoenzyme detection kit

Country Status (1)

Country Link
CN (1) CN104459158B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104865214A (en) * 2015-05-08 2015-08-26 浙江蓝森生物科技有限公司 Method, reagent and kit for quantitative determination of mitochondrial AST activity in human serum
CN106244671A (en) * 2016-08-30 2016-12-21 山东博科生物产业有限公司 A kind of stable aspartate aminotransferase checkout and diagnosis detection kit
CN107860729A (en) * 2017-11-08 2018-03-30 北京北检·新创源生物技术有限公司 A kind of stable reagent for being used to determine glutamic-oxalacetic transaminease
CN110018305A (en) * 2019-05-12 2019-07-16 武汉生之源生物科技股份有限公司 A kind of aspartate amino transferase Mitochondria Isoenzyme detection kit and application
CN110079581A (en) * 2019-05-14 2019-08-02 天津中成佳益生物科技有限公司 A kind of detection kit and detection method of aspartate amino transferase Mitochondria Isoenzyme

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60169766A (en) * 1984-02-14 1985-09-03 Sugiura Shinyaku Kaihatsu Kenkyusho:Kk Reagent for fractional measurement of soluble fraction aspartic acid aminotransferase and mitochondria aspartic acid aminotransferase
US4769323A (en) * 1984-01-12 1988-09-06 Sawao Murao Method for fractional determination of aspartate aminotransferase isozymes, and composition therefor
CN1546683A (en) * 2003-12-15 2004-11-17 上海北加生化试剂有限公司 Aspartic transaminase mitochondrion isozyme m type measurement method
CN102399851A (en) * 2011-10-25 2012-04-04 宁波美康生物科技有限公司 Sialidase detection kit
CN102946858A (en) * 2010-05-10 2013-02-27 英塔斯生物制药有限公司 Liquid formulation of polypeptides containing an Fc domain of an immunoglobulin

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769323A (en) * 1984-01-12 1988-09-06 Sawao Murao Method for fractional determination of aspartate aminotransferase isozymes, and composition therefor
JPS60169766A (en) * 1984-02-14 1985-09-03 Sugiura Shinyaku Kaihatsu Kenkyusho:Kk Reagent for fractional measurement of soluble fraction aspartic acid aminotransferase and mitochondria aspartic acid aminotransferase
CN1546683A (en) * 2003-12-15 2004-11-17 上海北加生化试剂有限公司 Aspartic transaminase mitochondrion isozyme m type measurement method
CN102946858A (en) * 2010-05-10 2013-02-27 英塔斯生物制药有限公司 Liquid formulation of polypeptides containing an Fc domain of an immunoglobulin
CN102399851A (en) * 2011-10-25 2012-04-04 宁波美康生物科技有限公司 Sialidase detection kit

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104865214A (en) * 2015-05-08 2015-08-26 浙江蓝森生物科技有限公司 Method, reagent and kit for quantitative determination of mitochondrial AST activity in human serum
CN106244671A (en) * 2016-08-30 2016-12-21 山东博科生物产业有限公司 A kind of stable aspartate aminotransferase checkout and diagnosis detection kit
CN107860729A (en) * 2017-11-08 2018-03-30 北京北检·新创源生物技术有限公司 A kind of stable reagent for being used to determine glutamic-oxalacetic transaminease
CN107860729B (en) * 2017-11-08 2022-03-11 北京北检·新创源生物技术有限公司 Stable reagent for determining glutamic-oxalacetic transaminase
CN110018305A (en) * 2019-05-12 2019-07-16 武汉生之源生物科技股份有限公司 A kind of aspartate amino transferase Mitochondria Isoenzyme detection kit and application
CN110018305B (en) * 2019-05-12 2020-12-08 武汉生之源生物科技股份有限公司 Aspartate aminotransferase mitochondrial isozyme detection kit and application
CN110079581A (en) * 2019-05-14 2019-08-02 天津中成佳益生物科技有限公司 A kind of detection kit and detection method of aspartate amino transferase Mitochondria Isoenzyme

Also Published As

Publication number Publication date
CN104459158B (en) 2016-06-22

Similar Documents

Publication Publication Date Title
CN104459158B (en) Aspartate aminotransferase Mitochondria Isoenzyme detection kit
CN102721684B (en) Two-step enzyme measuring method and measuring reagent for creatinine in blood serum
CN102154443B (en) Creatine jubase MB isozyme activity detection reagent and preparation method thereof
CN101717814B (en) Liquid double reagent diagnostic reagent kit for determining content of potassium ions in serum and blood plasma
CN104267178B (en) A kind of serum fucoside enzyme detection kit
CN105203472B (en) A kind of stable free fatty acid determination reagent kit
CN102072953B (en) A kind of stable enzyme process detects sialic method and test kit
CN104031637B (en) A kind of azo fluorescent probe and application thereof detecting biological hydrogen sulfide
CN104198420A (en) Stable detection kit of total bile acid
CN106501514A (en) Detection reagent for alanine aminotransferase box
CN104483487A (en) Kit for detecting 1, 5-anhydro-D-ghlcitol in human blood
CN104359906A (en) Serum total bile acid detection reagent with stable and strong anti-interference capability
CN102706818A (en) Enzymatic triglyceride measuring method and measuring reagent
Büttemeyer et al. In vivo measurement of oxygen‐derived free radicals during reperfusion injury
CN103528977A (en) Serum beta-hydroxybutyric acid reagent kit and assay method thereof
CN110261601A (en) A kind of homocysteine detection kit
CN106644976A (en) Aspartate amino transferase detection kit
CN105238847A (en) Stable adenosine deaminase reagent high in anti-interference capability and detection method
CN106244671B (en) Stable aspartate aminotransferase detects diagnosis detect reagent box
CN104865214A (en) Method, reagent and kit for quantitative determination of mitochondrial AST activity in human serum
BR112012018009A2 (en) non-destructive method for detecting machining burns of a very high strength steel and color chart for calibrating machining burns of said steel.
CN104561237A (en) Blood ammonia kit
CN105223192A (en) A kind of glycated serum protein detects reagent and application thereof
CN102010890B (en) Kit for determining mitochondria aspartate aminotransferase
CN104611319A (en) Method for improving thermal stability of liquid fructosaminase

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP01 Change in the name or title of a patent holder

Address after: 315104 Ningbo, Yinzhou, Central District, No. Qiming South Road, No. 299

Patentee after: Meikang biological Polytron Technologies Inc

Address before: 315104 Ningbo, Yinzhou, Central District, No. Qiming South Road, No. 299

Patentee before: Ningbo Meikang Biotechnology Co., Ltd.

CP01 Change in the name or title of a patent holder
CB03 Change of inventor or designer information

Inventor after: Zou Bingde

Inventor after: Zou Jihua

Inventor after: Lu Huixian

Inventor after: Huang Xinglei

Inventor before: Zou Bingde

Inventor before: Zou Jihua

Inventor before: Lu Huixian

Inventor before: Huang Xinlei

CB03 Change of inventor or designer information